Drug industry to decline data submission for drug costs.

The pharmaceutical industry declined, in an excuse of its business confidentiality, the cost data submission for manufactured and imported drugs requested by the MOHW.

The MOHW earlier called for the drug industry to submit the statement of drug manufacturing or imported costs until the end of February, but the KPMA and the KRPIA, a foreign multinational drug corporation group, delivered th...